NINDS to Fund Biomarkers for Spinal Muscular Atrophy | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Institute of Neurological Disorders and Stroke plans to award a $1.8 million grant next year to fund a study to evaluate biomarkers for spinal muscular atrophy (SMA).

SMA occurs in around 1 in 6,000 live births, is associated with a mutation in chromosome 5, and is among the most common genetic causes of infantile death.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.